7 children develop blood cancer after Bluebird gene therapy for rare neurological disease

It seems the lentivirus used to ferry the therapy disrupted a gene linked to cancer.

October 11, 2024 Check out STAT+

Sponsored By

Ruby Wallau for STAT STAT+ | 7 children developed blood cancer after Bluebird Bio gene therapy for rare neurological disease Additional cancer cases create difficult choices for families facing a devastating neurological disorder with few alternative treatments.   By Jason Mast STAT+ | GSK to pay up to $2.2 billion to settle most Zantac lawsuits over claims the heartburn pill causes cancer The settlement covers roughly 80,000 cases, or 93% of the suits that were outstanding in state courts around the U.S. By Ed Silverman A crack of light for Pfizer Today's biotech news updates include tragic news for seven children following Bluebird Bio treatment, a sliver of hope for Pfizer, and more. By Meghana Keshavan

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser